Compare MSM & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSM | TFX |
|---|---|---|
| Founded | 1941 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 5.8B |
| IPO Year | 1996 | 1994 |
| Metric | MSM | TFX |
|---|---|---|
| Price | $119.51 | $140.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 8 |
| Target Price | $96.20 | ★ $138.75 |
| AVG Volume (30 Days) | 557.9K | ★ 579.7K |
| Earning Date | 04-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.45% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.12 | 2.08 |
| Revenue | ★ $3,363,817,000.00 | $1,992,713,000.00 |
| Revenue This Year | $5.82 | $15.97 |
| Revenue Next Year | $5.26 | $5.15 |
| P/E Ratio | ★ $39.11 | $66.21 |
| Revenue Growth | ★ 4.99 | N/A |
| 52 Week Low | $78.80 | $100.18 |
| 52 Week High | $130.46 | $145.00 |
| Indicator | MSM | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 47.70 | 55.32 |
| Support Level | $118.14 | $129.65 |
| Resistance Level | $127.25 | $145.00 |
| Average True Range (ATR) | 2.89 | 3.29 |
| MACD | -0.16 | 0.17 |
| Stochastic Oscillator | 40.07 | 79.80 |
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations supplies. MSC primarily operates in North America, where it derives over 95% of its revenue.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.